Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
Illumina (NASDAQ: ILMN) has announced a live webcast of its upcoming investor session at the Advances in Genome Biology and Technology (AGBT) Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (NASDAQ: ILMN) has announced a live webcast of its upcoming investor session at the Advances in Genome Biology and Technology (AGBT) Conference. The investor fireside chat is scheduled for Tuesday, February 25, 2025, at 8:00am PT (11:00am ET).
The session will feature presentations from key executives including Jacob Thaysen (CEO), Ankur Dhingra (CFO), and Steve Barnard (CTO). Investors, analysts, and interested parties can access the webcast through Illumina's website Investor Info section or via the provided direct link.
Participants are advised to join ten minutes before the scheduled start time to ensure proper connection. A replay of the session will be available on Illumina's website for at least 30 days after the event.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was +1.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer).
Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link – (https://illumina-agbt-investor-session-feb-2025.open-exchange.net/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session.
A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Bonny Fowler
+1.740.641.5579
pr@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference-302379336.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.